Topics:
Pulmonary Hypertension
Summary
New!
Watch a video about the new ESC Guidelines presented at the ESC Congress 2009
03/02/2009 00:00:00
Current versions available to download
Current translated versions available to download:
Authors
Nazzareno Galie (Chairperson) ; Marius M. Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J. Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko ; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau
Withdrawal of sitaxentan in the treatment of pulmonary arterial hypertension
Endorsed by:
Table of contents: Full Text (ESC Clinical Practice Guidelines)
Part 1 to 6
- Preamble
- Introduction
- Definitions
- Clinical classification of pulmonary hypertension
- Pathology of pulmonary hypertension
- Pathobiology of pulmonary hypertension
- Genetics, epidemiology, and risk factors of pulmonary hypertension
Part 7.Pulmonary arterial hypertension (Group 1)
- Diagnosis
- Evaluation of severity
- Therapy
- Specific pulmonary aterial hypertension susbsets
Part 8.Pulmonary veno-occlusive disease & pulmonary capillary haemangiomatosis
- Pulmonary veno-occlusive disease
- Pulmonary capillary haemangiomatosis
Part 9 to 12
- Pulmonary hypertension due to left heart disease (group 2)
- Pulmonary hypertension due to lung diseases and:or hypoxamia (group 3)
- Chronic thromboembolic pulmonary hypertension (group 4)
- Definition of a pulmonary arterial hypertension referral centre
Previous versions
A complete list of ESC Clinical Practice Guidelines (current and previous versions) endorsed by ESC National Society Members is available here
2004 Pulmonary Arterial Hypertension EHJ Full Text